[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.206.12.79. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Original Contributions
December 1983

Valproate-Ethosuximide Combination Therapy for Refractory Absence Seizures

Author Affiliations

From the Mount Sinai School of Medicine and the Bronx Veterans Administration Medical Center, New York (Dr Rowan); and the Instituut voor Epilepsiebestrijding, Heemstede, the Netherlands (Drs Meijer and Meinardi, Ms de Beer-Pawlikowski, and Mr van der Geest).

Arch Neurol. 1983;40(13):797-802. doi:10.1001/archneur.1983.04050120047006
Abstract

• Five patients had absence seizures refractory to treatment with either ethosuximide or valproate sodium. To determine their response to combination therapy with the two drugs, four of the five had serial 24-hour intensive monitoring studies that included cable telemetric EEG recording, closed-circuit television observation, and frequent antiepileptic drug (AED) serum level determinations. The resultant data confirmed the clinical and EEG effects of serial alterations in AED programs. All five became seizure free with combination therapy. Combination therapy with ethosuximide and valproate should be considered in patients whose absence seizures do not respond to standard therapeutic measures.

×